BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

199 related articles for article (PubMed ID: 12755957)

  • 81. Characterization of V804M-mutated RET proto-oncogene associated with familial medullary thyroid cancer, report of the largest Turkish family.
    Basaran MN; Tuna MM; Karakılıç E; Doğan BA; İmga NN; Berker D; Güler S
    J Endocrinol Invest; 2015 May; 38(5):541-6. PubMed ID: 25501606
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Variable expressivity of familial medullary thyroid carcinoma (FMTC) due to a RET V804M (GTG-->ATG) mutation.
    Feldman GL; Edmonds MW; Ainsworth PJ; Schuffenecker I; Lenoir GM; Saxe AW; Talpos GB; Roberson J; Petrucelli N; Jackson CE
    Surgery; 2000 Jul; 128(1):93-8. PubMed ID: 10876191
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Medullary thyroid carcinoma: recent advances and management update.
    Marsh DJ; Learoyd DL; Robinson BG
    Thyroid; 1995 Oct; 5(5):407-24. PubMed ID: 8563482
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Role of RET codonic mutations in the surgical management of medullary thyroid carcinoma in pediatric age multiple endocrine neoplasm type 2 syndromes.
    Spinelli C; Di Giacomo M; Costanzo S; Elisei R; Miccoli P
    J Pediatr Surg; 2010 Aug; 45(8):1610-6. PubMed ID: 20713208
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Medullary thyroid carcinoma. Genetic screening and prophylactic thyroidectomies.
    Bergant D; Hocevar M
    Acta Chir Iugosl; 2003; 50(3):121-4. PubMed ID: 15179767
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Pheochromocytoma and medullary thyroid carcinoma in a pregnant multiple endocrine neoplasia-2A patient.
    Sarathi V; Bandgar TR; Menon PS; Shah NS
    Gynecol Endocrinol; 2011 Aug; 27(8):533-5. PubMed ID: 20672905
    [TBL] [Abstract][Full Text] [Related]  

  • 87. [Decision making in postoperative incidentally found small C-cell-carcinoma].
    Raffel A; Cupisti K; Krausch M; Eisenberger CF; Knoefel WT
    Zentralbl Chir; 2005 Oct; 130(5):434-9. PubMed ID: 16220440
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Prophylactic thyroidectomy in MEN 2A syndrome.
    Mattavelli F; Seregni E; Collini P; Pasini B; Aiello A; Barbaccia C; Bimbi G; Riccio S; Santamaria S
    Tumori; 2003; 89(5):553-5. PubMed ID: 14870785
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Two cases of medullary thyroid carcinoma.
    Jong M; Sundram FX
    Ann Acad Med Singap; 2001 Nov; 30(6):646-50. PubMed ID: 11817297
    [TBL] [Abstract][Full Text] [Related]  

  • 90. The surgical treatment of medullary thyroid carcinoma.
    Evans DB; Fleming JB; Lee JE; Cote G; Gagel RF
    Semin Surg Oncol; 1999; 16(1):50-63. PubMed ID: 9890740
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Medullary thyroid cancer.
    Clayman GL; el-Baradie TS
    Otolaryngol Clin North Am; 2003 Feb; 36(1):91-105. PubMed ID: 12803011
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Acceptable age for prophylactic surgery in children with multiple endocrine neoplasia type 2a.
    Kahraman T; de Groot JW; Rouwe C; Hofstra RM; Links TP; Sijmons RH; Plukker JT
    Eur J Surg Oncol; 2003 May; 29(4):331-5. PubMed ID: 12711285
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Long-term outcome after DNA-based prophylactic neck surgery in children at risk of hereditary medullary thyroid cancer.
    Machens A; Dralle H
    Best Pract Res Clin Endocrinol Metab; 2019 Aug; 33(4):101274. PubMed ID: 31043326
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Alternative surgical strategies and favorable outcomes in patients with medullary thyroid carcinoma in Japan: experience of a single institution.
    Ito Y; Miyauchi A; Yabuta T; Fukushima M; Inoue H; Tomoda C; Uruno T; Kihara M; Higashiyama T; Takamura Y; Miya A; Kobayashi K; Matsuzuka F
    World J Surg; 2009 Jan; 33(1):58-66. PubMed ID: 19005720
    [TBL] [Abstract][Full Text] [Related]  

  • 95. C-cell cancer--prevention and treatment.
    Gimm O; Dralle H
    Langenbecks Arch Surg; 1999 Feb; 384(1):16-23. PubMed ID: 10367625
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Occult sporadic medullary microcarcinoma with lymph node metastases.
    Sironi M; Cozzi L; Pareschi R; Spreafico GL; Assi A
    Diagn Cytopathol; 1999 Sep; 21(3):203-6. PubMed ID: 10450108
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Medullary thyroid carcinoma.
    Moley JF
    Curr Treat Options Oncol; 2003 Aug; 4(4):339-47. PubMed ID: 12943614
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Medullary thyroid cancer.
    Kebebew E; Clark OH
    Curr Treat Options Oncol; 2000 Oct; 1(4):359-67. PubMed ID: 12057161
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Extension of Prophylactic Surgery in Medullary Thyroid Carcinoma. Differences Between Sporadic and Hereditary Tumours According to Calcitonin Levels and Lymph Node Involvement.
    Juez LD; Mercader E; Amunategui I; Febrero B; Rodríguez JM; Gómez-Ramírez J;
    World J Surg; 2022 Apr; 46(4):820-828. PubMed ID: 35089388
    [TBL] [Abstract][Full Text] [Related]  

  • 100. Familial thyroid cancer.
    Alsanea O; Clark OH
    Curr Opin Oncol; 2001 Jan; 13(1):44-51. PubMed ID: 11148685
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.